Myriad Oncology Blog


We believe that when it comes to cancer, our genetic tests provide critical information for both providers and patients. Follow our blog to learn more about our solutions.
Eric Rosenthal, PhD, ScM, LGC

riskScore® Validation

A 41-year-old woman without a personal history of cancer presents to her provider to better understand her risk of breast cancer.

Myriad Oncology

Cost of Myriad myRisk Testing

  Cost should never be a barrier when patients need genetic testing. That’s why it’s Myriad’s promise to make testing accessible and affordable. For patients

Myriad Oncology

Variant Reclassification

Why is Variant Reclassification in Hereditary Cancer Testing Important? Variant classification is a key component of germline testing, allowing patients to have an accurate answer

Stephanie Percich, MS, CGC

An Overview of riskScore

Myriad’s riskScore helps to refine a woman’s risk of breast cancer, with or without a family history of breast cancer.

Myriad Oncology

Myriad Corporate Statement

We are heartbroken over the systemic discrimination and racism that have persisted in this nation for too long. We have been quiet in reflection but

Website Feedback